As the innovators behind a new, data-driven ecosystem that reduces medical claim costs and promotes quality healthcare, Vālenz™ joins the World Health Organization in recognizing 2020 as the Year of the Nurse. Integral to Valenz’s services is its team of nurse case managers, who work closely with patients, providers, employers and payers to target the most appropriate levels of care before services are rendered, resulting in substantial savings for plans and members.
“Nurse case managers are essential to the Valenz promise of engaging early and often for smarter, better, faster healthcare,” said Amy Gasbarro, President of Vālenz Care, a triple-URAC accredited solution within the firm’s complete healthcare administrative ecosystem. “Their work improves quality and outcomes while also empowering our clients to move from reactive plan models to proactive population health management.”
For patients, nurse case managers are advocates for high-quality, lower-cost care – and many registered nurses on the Valenz team specialize in common and costly health conditions such as diabetes, cancer and pregnancy, among others. For self-insured employers and other professional stakeholders, nurse case managers help manage health administrative costs and quality by reducing expensive, unnecessary and/or preventable emergency room visits, hospitalizations, tests and other high-dollar claim events.
“Driven by actionable data — both individualized and aggregated — our Case Management solution ensures comprehensive care while minimizing out-of-pocket costs,” said Rob Gelb, Chief Revenue Officer of Valenz. “Our nurses serve as a central point of contact, guiding clients through treatment, so they can focus on what matters most — returning to good health.”
For all these reasons and more, says Gelb, Valenz is proud to celebrate the incredible impact of nursing excellence – this year and every year. For more information about Valenz Care, call (877) 601-2200.
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Visit Great Point at www.gppfunds.com.
Vālenz Introduces v-Lens, Industry’s Most Complete Reporting, Analytics Program
/in Announcements, Featured /by Maris PanjadaPHOENIX, Ariz. (March 24, 2020) – In the latest illustration of its company-wide commitment to innovation and collaboration, Vālenz™ has announced the launch of v-Lens, a complete reporting and analytics program for the self-insured employer and payer communities.
For self-insured employers, third party administrators and payers, insights from v-Lens enable greater, more data-driven collaboration with health plan partners – partners now equipped with the most comprehensive platform of actionable drill-down data available. The result is more strategic, proactive decision-making on behalf of employers, which means engaging early and often for smarter, better, faster healthcare.
“With healthcare costs continuing to rise every year, using data to more strategically manage claim administration has become paramount,” said Denny Johnson, Senior Sales Executive at Valenz. To make smarter decisions, employers and their health plan partners need to understand what drives the numbers behind their healthcare spending and how they can better manage those drivers to control the trends. “If an organization is managing healthcare costs using old assumptions, they are probably overlooking the very drivers that most expose them to significantly adverse outcomes,” Johnson added.
As a proprietary layer of the complete Vālenz ecosystem, v-Lens is fueled by integrated data from Valenz’s four core solutions: claim management, care management, high-value networks and payment integrity. It is also supported with top industry sources and evidence-based guidelines to ensure a holistic view of all factors related to cost, payment, utilization, quality and more.
“Looking at plan performance through v-Lens continuously uncovers new opportunities to improve costs without compromising quality,” said Valenz Chief Executive Officer Rob Gelb. “Through advanced analytics and predictive modeling, v-Lens enables more proactive decision making – and thanks to robust integration within the Valenz ecosystem, those decisions are immediately actionable and quickly beneficial.”
To learn more about v-Lens, visit valenzhealth.com/vlens.
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.
A Brief Message on COVID-19 Testing from Vālenz CEO
/in Announcements, Featured /by Maris PanjadaWe are pleased to see the IRS waive cost sharing for COVID-19 testing for workers enrolled in High Deductible Health Plans (HDHP). Based on conversations with several of our clients, we will likely see self-insured employers with other plan types follow suit. This is a good first step. So is the use of telehealth to reduce the impact on crowded emergency and urgent care centers by delivering a safe, alternative path to medical guidance, especially for plan members who may be considered in lower risk categories. As the nation’s first data-driven health administrative ecosystem, we are strong proponents for engaging early and often to help our clients achieve smarter, better, faster healthcare. Despite these challenging times, there are creative and proactive practices to remove barriers to care and treatment for plan members, employees, patients – let’s work together to put them into play.
Vālenz Welcomes Brittney Parrish as Senior Client Services Executive
/in Announcements, Featured /by Maris PanjadaPHOENIX, Ariz. (March 2, 2020) – Vālenz™, a leading innovator for data-driven solutions that reduce medical claim costs and promote quality healthcare, is pleased to announce that Brittney Parrish has joined the team as Senior Client Services Executive. With nearly 15 years’ experience in sales and account management in the health industry, Parrish is highly skilled in business development and client services, including managing large territories and identifying growth opportunities.
Parrish comes to Valenz from Preferred Medical, where, as Regional Account Manager, she was responsible for managing sales, service and relationship-building. Her prior work experience also includes sales positions at GENEX Services and Johnson & Johnson.
“I am excited to join this industry-leading team and support its data-driven vision of reducing costs for clients while enhancing quality of care,” Parrish said. “Through the complete Valenz health administrative ecosystem, I look forward to delivering solutions to clients that result in better health outcomes at lower costs.”
A graduate of the University of Richmond, Parrish’s skill sets include strategic sales planning, account analysis and development, client service, and negotiations – all key to her new role at Valenz, according to Tom Cox, Vice President, Client Services.
“Brittney brings many strengths that support our ongoing commitment to growing our services and client base,” Cox said. “As we continue to expand our analytic and predictive capabilities to provide smarter, better, faster healthcare for our clients, we are proud to have her on our team.”
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.
Darcey Dearden Joins Vālenz as Senior Sales Executive
/in Announcements, Featured /by Maris PanjadaPHOENIX, Ariz. (February 24, 2020) – Vālenz™, a leading innovator for data-driven solutions that reduce medical claim costs and promote quality healthcare, welcomes Darcey Dearden as Senior Sales Executive. An award-winning sales professional for more than 20 years, Dearden has a proven record of consistently exceeding performance goals and building strong relationships with clients and referral partners.
Prior to joining Valenz, Dearden was Regional Vice President for Total Administrative Services Corporation, the nation’s largest privately held third-party benefits administrator. There, she elevated underperforming teams and established new standards to enhance accountability, collaboration and production. Her work experience also includes sales management positions at BenefitMall and Paychex.
“Darcey offers a winning combination of excellence in sales leadership, team building, and uncovering new solutions that maximize efficiency and reduce costs,” said Rob Gelb, Chief Executive Officer. “Her skill sets in strategic execution and effective communication make her well positioned to help our clients achieve smarter, better, faster healthcare. She is an outstanding fit for our team.”
Dearden brings to Valenz a strong background in business-to-business sales, benefit administration and compliance. She says she is thrilled to join Valenz because, as the innovators behind the industry’s first complete health administrative ecosystem, Valenz embodies the future-focused, client-centric, data-driven vision necessary for lower-cost, higher-quality healthcare.
“I look forward to meeting and exceeding our clients’ needs with the leading-edge data science and solutions that are unique to the Valenz ecosystem,” Dearden said. “I share this company’s dedication to managing costs and improving quality of care, and it is an honor to be part of such a vibrant, growing team.”
For more information, call 877-601-2200.
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.
Vālenz Appoints Rob Gelb as Chief Executive Officer
/in Announcements, Featured /by Holly LawtonKey Leadership Moves Support Rapid Expansion of Industry’s First Health Administrative Ecosystem
PHOENIX, Ariz. (February 17, 2020) — The Board of Directors at Vālenz™ today announced the appointment of Rob Gelb as Chief Executive Officer. Gelb, who joined the firm in 2018 as Chief Revenue Officer, succeeds Josh Carder as CEO, while Carder assumes a new position as Chairman of the Board.
“When Josh founded this company 17 years ago, he did so with a vision to solve the complex administrative challenges affecting healthcare costs – and that vision still drives us today,” said Gelb. “It is an honor to be selected as CEO to continue moving forward through the power of innovation and next-generation data integration.”
Since joining Valenz, Gelb has been instrumental in integrating key acquisitions that created the foundation for the company’s single-source solutions and data analytics platform, also known as the Valenz health administrative ecosystem. Throughout his 30+ year career, he has held leadership positions at several prestigious firms, including York (now Sedgwick), Coventry, CIGNA and others.
“Rob is a highly esteemed leader with a proven record of strategic and tactical success in creating and expanding healthy companies, and I am thrilled that he is now taking the reins as CEO of Valenz,” said Carder, adding that he is equally excited to become Chairman of the Board, where he can continue to influence the Valenz vision and promise of smarter, better, faster healthcare.
In addition to Gelb’s appointment, the board announced that Amy Gasbarro has been appointed Chief Operating Officer. Read more about Gasbarro’s appointment here.
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. For more information, visit www.valenzhealth.com. Valenz is backed by Great Point Partners.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.
Vālenz Appoints Amy Gasbarro as Chief Operating Officer
/in Announcements, Featured /by Holly LawtonPHOENIX, Ariz. (February 17, 2020) — The Board of Directors at Vālenz™ has appointed Amy Gasbarro as Chief Operating Officer. Since 2018, Gasbarro has served as President of Vālenz Care, the firm’s care management solution.
“I commend the Board for their decision to appoint Amy to this role,” said Rob Gelb, the firm’s new Chief Executive Officer, adding that Gasbarro’s leadership background spans two decades at companies focused on population health and cost management solutions for self-funded employers. “Her expertise, combined with her shared vision for the future of Valenz, make her an excellent choice to oversee operations for the next high-growth phase of our company.”
In addition to her leadership role at Valenz, Gasbarro is actively involved in committees that advocate for self-insured employers, including the Government Relations Committee for the Self-Insurance Institute of America (SIIA) and the SIIA Political Action Committee. Such involvement ensures she has a seat at the table as a voice for self-funded groups, helping to steer public policy in support of favorable outcomes – namely, lower-cost, higher-quality healthcare.
Those outcomes are at the heart of everything they do at Valenz, says Gasbarro, where delivering on the company’s promise involves taking every opportunity to engage early and often for smarter, better, faster healthcare. As COO, Gasbarro is committed to supporting the Valenz team as the enterprise grows, and as its flagship platform – the industry’s first complete, end-to-end health administrative ecosystem – expands.
“Through the analytic and predictive power of the Valenz ecosystem, we are continuously broadening our ability to influence better health outcomes and reduce total cost of care,” said Gasbarro. “This is a very exciting time for Valenz, and I look forward to my new role in shaping a more prosperous future for our company, and more importantly, for our clients.”
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim), and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. For more information, visit www.valenzhealth.com. Valenz is backed by Great Point Partners.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. Learn more at www.gppfunds.com.
2020 Year of the Nurse: Vālenz Celebrates the Impact of Nursing Excellence
/in Featured, Valenz Care /by Adam LeeAs the innovators behind a new, data-driven ecosystem that reduces medical claim costs and promotes quality healthcare, Vālenz™ joins the World Health Organization in recognizing 2020 as the Year of the Nurse. Integral to Valenz’s services is its team of nurse case managers, who work closely with patients, providers, employers and payers to target the most appropriate levels of care before services are rendered, resulting in substantial savings for plans and members.
“Nurse case managers are essential to the Valenz promise of engaging early and often for smarter, better, faster healthcare,” said Amy Gasbarro, President of Vālenz Care, a triple-URAC accredited solution within the firm’s complete healthcare administrative ecosystem. “Their work improves quality and outcomes while also empowering our clients to move from reactive plan models to proactive population health management.”
For patients, nurse case managers are advocates for high-quality, lower-cost care – and many registered nurses on the Valenz team specialize in common and costly health conditions such as diabetes, cancer and pregnancy, among others. For self-insured employers and other professional stakeholders, nurse case managers help manage health administrative costs and quality by reducing expensive, unnecessary and/or preventable emergency room visits, hospitalizations, tests and other high-dollar claim events.
“Driven by actionable data — both individualized and aggregated — our Case Management solution ensures comprehensive care while minimizing out-of-pocket costs,” said Rob Gelb, Chief Revenue Officer of Valenz. “Our nurses serve as a central point of contact, guiding clients through treatment, so they can focus on what matters most — returning to good health.”
For all these reasons and more, says Gelb, Valenz is proud to celebrate the incredible impact of nursing excellence – this year and every year. For more information about Valenz Care, call (877) 601-2200.
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. More information is available online at valenzhealth.com. Valenz is backed by Great Point Partners.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Visit Great Point at www.gppfunds.com.
Vālenz Becomes SIIA Diamond Member
/in Announcements, Featured /by Adam LeePHOENIX, Ariz. (January 9, 2020) – Vālenz™ is pleased to announce that it has become a Diamond member company of the Self-Insurance Institute of America, Inc. (SIIA). Diamond membership signifies the highest level of support for SIIA and demonstrates a company’s leadership position within the self-insurance/captive insurance marketplace.
“We are proud and honored to support SIIA in its mission, and our recent decision to become a Diamond member reflects the strength of our commitment – and theirs – to serving the needs of the self-insured community,” said Valenz Chief Revenue Officer Rob Gelb. “Our involvement with SIIA over the years has been integral to our ability to develop innovative solutions that reduce medical claim costs and promote quality healthcare. Diamond member status is one of many ways we are giving back to an organization that has given so much to us, and to the self-insured community we serve daily.”
Through a complete health administrative ecosystem that connects cost and quality data on a single-source, end-to-end analytics platform, Valenz helps self-insured employers achieve smarter, better, faster healthcare at significant cost savings. By integrating data from its core services – which comprise care management, high-value provider networks, claim workflow management, payment integrity, revenue cycle management and eligibility compliance – Valenz delivers solutions that reduce total cost of care while improving health outcomes for America’s workforce.
The continued growth in the number of SIIA Diamond members reflects recognition by leading-industry companies of the importance to provide robust support to the trade association that is best positioned to protect and promote their business interests. This support has enabled SIIA to further improve and expand its membership service capabilities. Learn more at siia.org.
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners. To learn more about Valenz, visit www.valenzhealth.com
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Learn more at www.gppfunds.com.
Greg Shelley Joins Vālenz Team as Senior Client Services Executive
/in Announcements, Featured /by Holly LawtonPHOENIX, Ariz. (January 8, 2020) — In keeping with an ongoing commitment to expand its services and client base, leaders at Vālenz™ are pleased to announce the appointment of Greg Shelley as Senior Client Services Executive. Shelley joined the team at Vālenz – a leading innovator for solutions that connect cost and quality data on a single, end-to-end analytics platform to reduce medical claim costs and promote quality healthcare – in late December.
“Greg brings a unique mix of strengths to this role, including his skills in relationship-building, client service, strategic execution and data analysis,” said Rob Gelb, Chief Revenue Officer. “Those attributes, combined with his consultative spirit and passion for helping clients solve challenges, have positioned him well to bring new solutions to Valenz clients. We are proud to have him on board.”
“It’s an honor to join the Valenz team because the promise of ‘smarter, better, faster healthcare’ is so compelling and, more important, so in demand,” said Shelley. “More than most, the people of Valenz understand how to reduce the total cost of care and have been making the smart, strategic moves necessary to bring results-driven solutions to our clients.”
As a candidate, Shelley was drawn to the firm’s innovative approach to data science. Now, as a member of the team, he says he’s wholly inspired by it and looks forward to finding new ways to foster ongoing growth. With a degree in Business Administration from West Texas A&M University, Shelley has held a variety of management and leadership roles, most recently at One Call, a provider of healthcare solutions for the workers’ compensation industry, where he served as vice president of business development.
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. For more information, visit www.gppfunds.com.
Tom Cox, MBA, Joins Vālenz Team as Vice President of Client Services
/in Announcements, Featured /by Holly LawtonPHOENIX, Ariz. (January 8, 2020) — To support continuous expansion of the Vālenz™ ecosystem and deliver solutions that meet the ever-evolving needs of their clients and partners, Valenz officials today announced the appointment of Tom Cox, MBA, as Vice President of Client Services. Cox joins the team in mid-January to lead the client services and business development support teams.
“Tom has a deep conviction for delivering service excellence and creating value for clients, partners and shareholders,” said Rob Gelb, Chief Revenue Officer. “His leadership experience and ability to leverage data for client solutions have positioned him well to head up our client services team.”
Cox says he has always been passionate about delivering service excellence because he believes great service is the key to strong, long-lasting relationships. In addition to overseeing client services – the first point of contact for the firm’s large and growing client base – Cox plays a key role in data-driven growth and development of existing business.
“With healthcare as complex as it is, I am really excited about the depth of Valenz analytics,” said Cox. “We have a great line of sight into client trends and needs, allowing us to pinpoint opportunities to truly bend the cost curve in healthcare.”
Having held a number of leadership positions in customer service, most recently at Philadelphia Insurance Companies and Aqua America, Cox brings extensive experience to his new role. He earned his master’s degree from Arcadia University in Pennsylvania after completing his bachelor’s degree in psychology from the State University of New York at Albany. He is also nationally certified in coaching, training and facilitation. His education, combined with more than a decade of versatile business experience, has inspired Cox to deliver creative approaches, fresh thinking and data-driven insights to service delivery.
About Valenz
Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. For more information, visit www.gppfunds.com.